SK282635B6 - [1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a] chinoxalinónových zlúčenín a ich použitie - Google Patents

[1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a] chinoxalinónových zlúčenín a ich použitie Download PDF

Info

Publication number
SK282635B6
SK282635B6 SK335-97A SK33597A SK282635B6 SK 282635 B6 SK282635 B6 SK 282635B6 SK 33597 A SK33597 A SK 33597A SK 282635 B6 SK282635 B6 SK 282635B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
triazolo
quinoxalin
trifluoromethyl
Prior art date
Application number
SK335-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK33597A3 (en
Inventor
Flemming Elmelund Nielsen
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of SK33597A3 publication Critical patent/SK33597A3/sk
Publication of SK282635B6 publication Critical patent/SK282635B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK335-97A 1994-09-16 1995-09-12 [1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a] chinoxalinónových zlúčenín a ich použitie SK282635B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK106594 1994-09-16
PCT/DK1995/000364 WO1996008492A1 (en) 1994-09-16 1995-09-12 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE

Publications (2)

Publication Number Publication Date
SK33597A3 SK33597A3 (en) 1998-02-04
SK282635B6 true SK282635B6 (sk) 2002-10-08

Family

ID=8100599

Family Applications (1)

Application Number Title Priority Date Filing Date
SK335-97A SK282635B6 (sk) 1994-09-16 1995-09-12 [1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a] chinoxalinónových zlúčenín a ich použitie

Country Status (23)

Country Link
US (1) US6001832A (zh)
EP (1) EP0783504B1 (zh)
JP (1) JPH10505601A (zh)
CN (1) CN1083842C (zh)
AT (1) ATE190616T1 (zh)
AU (1) AU706737B2 (zh)
CA (1) CA2200055A1 (zh)
CZ (1) CZ285248B6 (zh)
DE (1) DE69515680T2 (zh)
DK (1) DK0783504T3 (zh)
ES (1) ES2146769T3 (zh)
FI (1) FI971075A (zh)
GR (1) GR3033642T3 (zh)
HU (1) HUT76810A (zh)
IL (1) IL115300A (zh)
NO (1) NO308796B1 (zh)
NZ (1) NZ292107A (zh)
PL (1) PL319176A1 (zh)
PT (1) PT783504E (zh)
RU (1) RU2149162C1 (zh)
SK (1) SK282635B6 (zh)
WO (1) WO1996008492A1 (zh)
ZA (1) ZA957795B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024434A1 (en) 1997-11-11 1999-05-20 Ono Pharmaceutical Co., Ltd. Fused pyrazine compounds
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
AU2010219598A1 (en) 2009-03-05 2011-09-22 Astellas Pharma Inc. Quinoxaline compounds
CA2810659A1 (en) 2010-09-07 2012-03-15 Astellas Pharma Inc. Quinoxaline compound
BR112013005855A2 (pt) * 2010-09-16 2016-05-17 Hutchison Medipharma Ltd heteroarilas fundidas e seus usos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) * 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
DK162491D0 (da) * 1991-09-20 1991-09-20 Novo Nordisk As Heterocycliske forbindelser, deres fremstilling og farmaceutiske praeparater indeholdende forbindelserne
AU3767793A (en) * 1992-04-03 1993-11-08 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same
DK31093D0 (zh) * 1993-03-19 1993-03-19 Novo Nordisk As
WO1994026746A1 (en) * 1993-05-06 1994-11-24 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE

Also Published As

Publication number Publication date
JPH10505601A (ja) 1998-06-02
ATE190616T1 (de) 2000-04-15
WO1996008492A1 (en) 1996-03-21
SK33597A3 (en) 1998-02-04
RU2149162C1 (ru) 2000-05-20
CZ285248B6 (cs) 1999-06-16
IL115300A (en) 2001-06-14
FI971075A (fi) 1997-05-13
EP0783504B1 (en) 2000-03-15
CN1083842C (zh) 2002-05-01
NO971186L (no) 1997-05-15
DE69515680D1 (de) 2000-04-20
PT783504E (pt) 2000-08-31
AU3380795A (en) 1996-03-29
DE69515680T2 (de) 2000-10-19
DK0783504T3 (da) 2000-08-14
US6001832A (en) 1999-12-14
AU706737B2 (en) 1999-06-24
CZ75497A3 (en) 1997-08-13
CN1193974A (zh) 1998-09-23
NO971186D0 (no) 1997-03-14
IL115300A0 (en) 1995-12-31
EP0783504A1 (en) 1997-07-16
GR3033642T3 (en) 2000-10-31
ZA957795B (en) 1996-05-14
NO308796B1 (no) 2000-10-30
HUT76810A (en) 1997-11-28
PL319176A1 (en) 1997-08-04
FI971075A0 (fi) 1997-03-14
NZ292107A (en) 1999-02-25
ES2146769T3 (es) 2000-08-16
CA2200055A1 (en) 1996-03-21

Similar Documents

Publication Publication Date Title
EP0698024B1 (en) [1,2,4]TRIAZOLO [4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE
CZ138793A3 (en) Quinoxaline derivatives, process of their preparation and their use in medicaments
US5559106A (en) Heterocyclic compounds, their use and preparation
IL103160A (en) Pharmaceuticals Containing 1,2,4 [Triazolo] -A] 4,3 Quinoxaline-4-Ones and 1,4Dions for the treatment of indications related to neurotransmitter overactivity
EP0865442B1 (en) IMIDAZO[1,2-a]QUINOXALIN-4-AMINES ACTIVE AS ADENOSINE ANTAGONISTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THEREOF
SK282635B6 (sk) [1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a] chinoxalinónových zlúčenín a ich použitie
EP0743945B1 (en) Heterocyclic compounds and their preparation and use
SK282457B6 (sk) [1,2,4]Triazolo[4,3-a]chinoxalinónové zlúčeniny, farmaceutický prostriedok, spôsob prípravy [1,2,4]triazolo[4,3-a]chinoxalinónových zlúčenín a ich použitie